[{"Assets_0_Q1_USD":88855000.0,"CommonStockSharesOutstanding_0_Q1_shares":94696272.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-11766000.0,"NetIncomeLoss_1_Q1_USD":-33126000.0,"StockholdersEquity_0_Q1_USD":47705000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":486000.0,"Ticker":"EYPT","CIK":"1314102","name":"EYEPOINT PHARMACEUTICALS, INC.","OfficialName":"EyePoint Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"408871503.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181109"}]